Martha Raymond Provides an Overview of the Colon Cancer Alliance

Video

Martha Raymond, patient support and outreach director, Colon Cancer Alliance, gives an overview of the advocacy organization and some of the services it provides.

Martha Raymond, Vice President of Programs, Colon Cancer Alliance, gives an overview of the advocacy organization and some of the services it provides.

The Colon Cancer Alliance was founded in 1999 and offers programs in patient support, empowerment and education. The organization also offers a signature patient navigator program. Even though the program just started at the beginning of the year, it has already helped thousands of colorectal cancer patients on their journey.

For more information on the Colon Cancer Alliance, visit http://www.ccalliance.org.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
4 experts in this video
4 experts in this video
Image of a woman with light brown hair wearing glasses with a blue background
Image of a woman wearing glasses in front of a blue background
Image of a woman with glasses in front of a blue background
Image of a man in a suit smiling in front of an Oncology Nursing News background
Image of a woman wearing a patterned shirt in front of a dark blue background
Photo of a woman wearing a blazer in front of an Oncology Nursing News backdrop
3 experts in this video
3 experts in this video
Related Content
Anatomical image of a pancreas with tumors

Atebimetinib Combo Shows Survival Signal in First-Line Pancreatic Cancer

Chris Ryan
June 22nd 2025
Article

The novel MEK inhibitor atebimetinib plus chemotherapy showed early signs of survival benefit in first-line treatment of patients with pancreatic cancer.

The Vitals

ctDNA Monitoring is a Piece of the Puzzle in CRC Treatment

Lindsay Fischer
October 31st 2023
Podcast

Holly Chitwood, DNP, FNP-C, AGACNP-BC, explains how circulating tumor DNA monitoring helps providers screen minimal residual disease in individuals with colorectal cancer.

Anatomical rendering of the human body with the colon highlighted

Panitumumab Improves Outcomes in RAS/BRAF Wildtype Colon Cancer

Tony Berberabe, MPH
May 22nd 2025
Article

Adding panitumumab to neoadjuvant FOLFOX cut recurrence risk and improved survival in locally advanced, RAS/BRAF wild-type colon cancer.

The Vitals

Terri Pollack Offers Perspective on 2023 ASCO GI Cancers Symposium

Lindsay Fischer
March 1st 2023
Podcast

In this episode of "The Vitals," Terri Pollack, DNP, APRN, FNP-C, PMHNP-BC, underscores potentially practice-changing data which were presented during the 2023 GI Cancers Symposium.

pancreatic ductal adenocarcinoma

Proactive Management of NALIRIFOX-Related Diarrhea Is Crucial in Metastatic PDAC

Ashley Chan
April 12th 2025
Article

Assessing the signs and symptoms of chemotherapy-induced diarrhea and providing accurate and timely patient education may reduce complications and optimize survival outcomes.

Graphic reading "FDA APPROVED" resembling a stamp of approval

Cabozantinib Approved for Unresectable, Advanced/Metastatic epNET and pNET

Bridget Hoyt
March 26th 2025
Article

The FDA approved cabozantinib for use in patients with previously treated unresectable, locally advanced or metastatic, well-differentiated epNETs or pNETs.